Opinions in Healthcare

Onyda XR

On May 24, 2024, the FDA approved Onyda XR (clonidine hydrochloride), a liquid non-stimulant medication for attention deficit hyperactivity disorder (ADHD). Developed by Tris Pharma, Onyda XR is a centrally acting alpha 2

Read More

Wegovy Shortage

In recent months, there has been a surge in clinicians prescribing subcutaneous injections for weight loss to their patients. As a result, manufacturers have struggled to keep up with the increased demand. Pharmacies

Read More

Opill

On July 13, 2023, the FDA approved the first over-the-counter birth control called ‘Opill’. An increased availability of hormonal birth control without a prescription may increase access and remove the barriers that individuals

Read More

Beyfortus

On July 18th, 2023, the FDA approved Beyfortus (nirsevimab-alip) for the prevention of Respiratory Syncytial Virus (RSV) in neonates and infants born during or entering their first RSV season, and in children up

Read More